Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial

202219 citationsJournal Articlehybrid Open Access

Authors

A tapering dose regimen of lisdexamfetamine was safe and feasible for the treatment of acute methamphetamine withdrawal in an inpatient setting.

Good health and well-being

Published in: Drug and Alcohol Dependence

Volume 241, pp. 109692-109692

Field-Weighted Citation Impact: 2.68